Ciclesonide nasal spray: In allergic rhinitis

Drugs

Volumn 68, Issue 6, 2008, Pages 875-883

  Dhillon, Sohita ^a,b   Wagstaff, Antona J ^a,b  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

^b WOLTERS KLUWER HEALTH   (United States)

Author keywords

Adis Drug Profiles; Allergic rhinitis, treatment; Ciclesonide, general

Indexed keywords

BECLOMETASONE; BUDESONIDE; CICLESONIDE; DEXAMETHASONE; ERYTHROMYCIN; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; KETOCONAZOLE; MOMETASONE FUROATE; PLACEBO;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BINDING AFFINITY; BRONCHITIS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COUGHING; DISEASE EXACERBATION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG EXPOSURE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPISTAXIS; EYE IRRITATION; FOOD AND DRUG ADMINISTRATION; HAY FEVER; HEADACHE; HUMAN; INFLUENZA; MONOTHERAPY; NONHUMAN; NOSE DISEASE; OTALGIA; PERENNIAL RHINITIS; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; RHINOPHARYNGITIS; SINGLE DRUG DOSE; SINUS HEADACHE; SINUSITIS; SORE THROAT; STATISTICAL SIGNIFICANCE; TREATMENT INDICATION; UPPER RESPIRATORY TRACT INFECTION; URTICARIA;

ADMINISTRATION, INTRANASAL; AEROSOLS; ANTI-ALLERGIC AGENTS; HUMANS; PREGNENEDIONES; QUALITY OF LIFE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; TREATMENT OUTCOME;

EID: 42249094909     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200868060-00009     Document Type: Review

References (27)

1. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc 2007 Jan-Feb; 28 (1): 3-9
2. Bousquet J, Khaltaev N, Cruz A, et al. Allergic Rhinitis and its Impact on Asthma: ARIA report 2007 [online]. Available from URL: http://www.whiar.org/ docs/ARIA_WR_wm.pdf [Accessed 2008 Mar 12]
3. Price D, Bond C, Bouchard J, et al. International Primary Care Respiratory Group (IPCRG) Guidelines: management of allergic rhinitis. Prim Care Respir J 2006 Feb; 15 (1): 58-70
4. Meltzer EO. Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Ann Allergy Asthma Immunol 2007 Jan; 98 (1): 12-21
5. Nycomed US Inc. Omnaris (ciclesonide) nasal spray, 50 mcg: US prescribing information [online]. Available from URL: http://www.fda.gov/cder/foi/label/ 2007/022124lbl.pdf [Accessed 2008 Mar 12]
6. FDA. Medical review: Omnaris nasal spray [online]. Available from URL: http://www.fda.gov/cder/foi/nda/2006/022004s000_MedR.pdf [Accessed 2008 Mar 13]
7. Sato H, Nave R, Nonaka T, et al. In vitro metabolism of ciclesonide in human nasal epithelial cells. Biopharm Drug Dispos 2007 Jan; 28 (1): 43-50
8. Belvisi MG, Bundschuh DS, Stoeck M, et al. Preclinical profile of ciclesonide, a novel corticosteroid for the treatment of asthma. J Pharmacol Exp Ther 2005 Aug; 314 (2): 568-74
9. Winkler J, Hochhaus G, Derendorf H. How the lung handles drugs: pharmacokinetics and pharmacodynamics of inhaled corticosteroids. Proc Am Thorac Soc 2004; 1 (4): 356-63
10. Silvestri M, Serpero L, Petecchia L, et al. Cytokine-activated bronchial epithelial cell pro-inflammatory functions are effectively downregulated in vitro by ciclesonide. Pulm Pharmacol Ther 2006; 19 (3): 210-7
11. Stoeck M, Riedel R, Hochhaus G, et al. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide. J Pharmacol Exp Ther 2004 Apr; 309 (1): 249-58
12. Ratner PH, Wingertzahn MA, van Bavel JH, et al. Efficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2006; 118 (5): 1142-8
13. Meltzer EO, Kunjibettu S, Hall N, et al. Efficacy and safety of ciclesonide, 200 μg once daily, for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol 2007 Feb; 98 (2): 175-81
14. Schmidt BM, Timmer W, Georgens AC, et al. The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis. J Clin Pharmacol 1999 Oct; 39 (10): 1062-9
15. Rohatagi S, Luo Y, Shen L, et al. Protein binding and its potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide. Am J Ther 2005; 12 (3): 201-9
16. Derendorf H, Nave R, Drollmann A, et al. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J 2006 Nov; 28 (5): 1042-50
17. Hochhaus G, Wu K, Blomgren AL, et al. How do differences in tissue and protein binding affect pulmonary pharmacodynamics: ciclesonide vs budesonide [abstract no. A189]. 103rd International Conference of the American Thoracic Society; 2007 May 18-23; San Francisco (CA)
18. Nave R, Wingertzahn MA, Brookman S, et al. Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis. J Clin Pharmacol 2006 Apr; 46 (4): 461-7
19. Ratner P, Darken P, Wingertzahn M, et al. Ciclesonide and beclomethasone dipropionate coadministration: effect on cortisol in perennial allergic rhinitis. J Asthma 2007; 44 (8): 629-33
20. Kim K, Quesada J, Szmaydy-Rikken N, et al. Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients. J Asthma 2007 Sep; 44 (7): 515-20
21. 14C]ciclesonide after oral and intravenous administration to healthy subjects. Clin Pharmacokinet 2004; 43 (7): 479-86
22. Wingertzahn M A, Takanashi K, Nagano A. Persistence and effusion clearance to esophagus of ciclesonide in hypotonic and isotonic suspensions [abstract no. 1008]. J Allergy Clin Immunol 2006 Feb; 117 (2 Suppl. 1): S260. Plus poster presented at the 62nd Annual Meeting of the American Academy of Allergy, Asthma and Immunology; 2006 Mar 3-8; Miami Beach (FL)
23. Peet CF, Enos T, Nave R, et al. Identification of enzymes involved in phase I metabolism of ciclesonide by human liver microsomes. Eur J Drug Metab Pharmacokinet 2005; 30 (4): 275-86
24. Rohatagi S, Arya V, Zech K, et al. Population pharmacokinetics and pharmacodynamics of ciclesonide. J Clin Pharmacol 2003 Apr; 43 (4): 365-78
25. Nave R, Drollmann A, Steinijans VW, et al. Lack of pharmacokinetic drug-drug interaction between ciclesonide and erythromycin. Int J Clin Pharmacol Ther 2005 Jun; 43 (6): 264-70
26. Ratner PH, Wingertzahn MA, van Bavel JH, et al. Effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2006 Nov; 97 (5): 657-63
27. Chervinsky P, Kunjibettu S, Miller DL, et al. Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol 2007 Jul; 99 (1): 69-76